https://scholars.lib.ntu.edu.tw/handle/123456789/620244
Title: | Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial | Authors: | Drakaki A. Kirby C.J. Van Der Heijden M.S. Petrylak D.P. Powles T. Chi K.N. Fl?chon A. Necchi A. G?czi L. Lee J.-L. Gakis G. Bracarda S. Chowdhury S. CHIA-CHI LIN Keizman D. Vaishampayan U.N. Zimmermann A.H. Bell-Mcguinn K. Castellano D. |
Issue Date: | 2020 | Publisher: | IOS Press | Journal Volume: | 6 | Journal Issue: | 1 | Start page/Pages: | 43-52 | Source: | Bladder Cancer | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083061281&doi=10.3233%2fBLC-190252&partnerID=40&md5=782a8cf8c84e2098fa375754c885810d https://scholars.lib.ntu.edu.tw/handle/123456789/620244 |
ISSN: | 2352-3727 | DOI: | 10.3233/BLC-190252 |
Appears in Collections: | 臨床醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.